Pediatric and adult patients experienced noninferior and robust immune responses to RIV4, as well as similar safety profiles.

A virus from humble black-eyed peas is showing extraordinary promise in the fight against cancer. Unlike other plant viruses, ...

A virus that typically infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy—and ...

In a study published in Cell Biomaterials, a team led by chemical and nano engineers at the University of California San ...

Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, ...

Researchers have taken a closer look at how the cowpea mosaic virus (CPMV), unlike other plant viruses, is uniquely effective ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

A virus that typically infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy—and researchers are uncovering ...

The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Poster presentation of updated data on BT-001 from the Phase 1 part of the ongoing Phase 1/2a study in solid tumors - LUND, SE / ACCESS Newswire / July 28, 2025 / BioInvent International AB ("BioInven ...